Early Treatment Failure in Patients With Relapsed/Refractory Multiple Myeloma Receiving Bispecific T-Cell Engagers: Development and Validation of the CHARGE Prognostic Index.
Listen to this summary
This study developed and externally validated the CHARGE index, a prognostic score for predicting progression-free survival in relapsed/refractory multiple myeloma patients receiving BCMA- or GPRC5D-directed bispecific T-cell engagers. Six readily available factors (high-risk cytogenetics, hyperferritinemia, anemia, early relapse, poor performance status, and prior BCMA-directed therapy) stratified patients into low-, intermediate-, and high-risk groups with median PFS of 21.8, 7.1, and 1.6 months, respectively, and these distinctions held in an independent cohort. The index offers a simple, validated tool to guide prognosis and identify patients at high risk of early treatment failure with bispecific T-cell engagers.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from Journal of clinical oncology : official journal of the American Society of Clinical Oncology
View all →Nov 20, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Alectinib as Neoadjuvant Treatment in Potentially Resectable Stage III Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: ALNEO Phase II Trial (GOIRC-01-2020-ML42316).
Nov 20, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Effect of a Multidisciplinary Intervention on Fatigue in Lymphoma Survivors With Persistent Fatigue: A Randomized Controlled Trial (the REFUEL trial).
Nov 20, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Reach of State-Mandated Insurance Coverage for Fertility Preservation in Patients With Cancer.
Nov 17, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Partial-Breast Irradiation Versus Whole-Breast Irradiation for Low-Risk Invasive Breast Carcinoma: 5-Year Results of the Multicenter, Randomized, Phase III IRMA Trial.
Nov 13, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Dasatinib Dose Optimization With Weekend Drug Holiday for Improved Tolerability in Chronic Myeloid Leukemia (DasaHIT): A German Chronic Myeloid Leukemia Alliance Randomized Trial.
Nov 12, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Second Cancer Risk in Female Survivors of Hodgkin Lymphoma: A National Cohort Analysis Across Treatment Eras.
More in Pediatrics
View all →Nov 20, 2026 · Hormone research in paediatrics
Post-Menarcheal Height Gain After Gonadotropin-Releasing Hormone Agonist Treatment in Girls with Central Precocious Puberty.
Nov 20, 2026 · Hormone research in paediatrics
JUVENILE IDIOPATHIC ARTHRITIS IN CHILDREN WITH TYPE 1 DIABETES: IMPACT OF CURRENT MEDICAL TREATMENT OPTIONS ON ANTHROPOMETRY AND METABOLIC CONTROL.
Nov 20, 2026 · European heart journal
Acute pulmonary embolism: long-term cause-specific mortality in a Chinese nationwide registry.
Nov 20, 2026 · Journal of the American College of Cardiology
Lipid-Lowering Strategies in the Era of Early Atherosclerosis Detection: 2026 ACC Scientific Statement: A Report of the American College of Cardiology.
Nov 20, 2026 · American journal of respiratory and critical care medicine
Glucagon-Like Peptide-1 Agonists or Tezepelumab for Obesity-Associated Asthma: A Cohort Study.
Nov 19, 2026 · Developmental medicine and child neurology
Definition and classification of cerebral palsy operationalized by the Surveillance of Cerebral Palsy in Europe.
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


